Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By The Daily Reckoning (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

The High Cost of Cheap Money

% of readers think this story is Fact. Add your two cents.


This post The High Cost of Cheap Money appeared first on Daily Reckoning.

The stars were once again in their courses yesterday… oil was poured upon troubled waters… the dip was bought.

All was peace.

Following Monday’s sharp unpleasantness, the stock market went trampolining back.

Yet gravity reasserted itself today.

The Dow Jones Industrial Average fell 234 points earthward.

With it came the S&P 500 and Nasdaq Composite.

The first dropped 40 points. The second, 171.

Yet a question arises:

What explains Monday’s severities? Why did a Japanese sneeze give the world a 24-hour influenza?

And can you expect a relapse? Today we take up an inquiry.

Look to the “Carry Trade”

We begin with the “carry trade,” so-called.

What is it? And how did it carry over to global markets Monday? Stock Talk:

image 1

Thus the sweet cherry — yen — becomes the hot potato.

More Lucrative Than the S&P!

Bloomberg columnist John Authers notes the following:

Since 2000 the yen-peso carry trade has yielded more juice than the Standard & Poor’s 500.

And the Standard & Poor’s 500 has yielded tubs of juice.

Yet this year the Bank of Japan put a kink in the hose.

Inflation has been on the jump and the Bank of Japan sought to choke it off some.

In March — for the first time in 17 years — Japan’s central bank imposed an interest rate increase.

Last week it imposed a second. It was a modest increase of 25 basis points. It was an increase nonetheless.

And it shook the world.

Early Monday Japan’s Nikkei index absorbed a 12% whaling.

It then fanned into existence a nearly perfect global typhoon… assaulting each corner of Earth at electronic velocities.

“This Is Where It Gets Messy”

Reports CNN Business:

Meanwhile, the dollar weakened as the Federal Reserve strongly hinted at looming rate cuts, and U.S tech stocks declined. If you’re a carry trader, you headed for the exits. But so did everyone else.

This is where it gets messy…

The carry trade relies on borrowing, which means it’s a leveraged position. (As a general rule, whenever you hear of leverage in finance, think “high risk”).

Once even minor losses start to accrue, lenders are going to demand that you pony up more cash to cover your potential losses, a process known as a margin call. That may mean selling stocks to raise cash, or closing out the position completely.

“Not everybody will have a margin call at once, but the riskiest people might, and then they start to liquidate,” John Sedunov, a finance professor at the Villanova School of Business said. “And then that creates losses for people down the chain, and then they have to sell things, and then it’s just this kind of spiral.”

In today’s interlocking markets the foot bone is connected to the thigh bone is connected to the hip bone is connected to the backbone.

Before a fellow knows what has struck him, a rumpus in his foot bone has his backbone in siege.

This we witnessed on Monday.

Asia, Europe, the United States and more endured a mighty yet brief backache.

Is the ache over? Or are we in for a relapse?

Not Done by “Any Stretch”

“We are not done by any stretch,” warns Arindam Sandilya, co-director of JPMorgan Chase’s global foreign exchange strategy.

“The carry trade unwind… is somewhere between 50–60% complete,” he adds.

TS Lombard, meantime, says:

Our analysis of past volatility bouts shows that equities take four–five weeks, on average, before a sustained recovery begins. Markets tend to rebound on oversold conditions such as the current ones, but investors often sell into that strength, which can lead to a relapse. This is what happened, for instance, in 2018, an episode that bears strong similarities to the current one.

We may not have our answer — in this telling — for four–five weeks.

Goldman’s crackerjacks tremble that “we are not going down because of recession but because of an unwind of circa 20 trillion carry trades.

“Only BOJ can stop this,” they add.

The Bank of Japan Picks Its Poison

Poor Japan. Poor, poor Japan.

It has squirmed itself into a lovely pickle jar.

It has engorged itself upon cheap money for so long… it cannot even withstand a pinprick interest rate increase against inflation… without harpooning global markets.

Its debt-to-GDP ratio comes in at a cosmic 265% or some such.

Any ratio above 90%, research indicates, swamps an economy. It cannot much expand.

Imagine then a 265% ratio.

As events stand presently, Japan must gulp poison one — inflation — or poison two: global market collapse.

On Monday poison one went down the gullet. The Bank of Japan chose inflation.

Bank of Japan Deputy Governor Shinichi Uchida pledged to refrain from additional hikings while markets remain unstable.

Yet last week’s hiking was itself the mother of the instability.

How then can he hike again?

Here is the short answer: He cannot. Do you prefer the long answer? Here you have it:

He cannot.

Turning Japanese

This morning colleague Sean Ring of The Rude Awakening half-quipped that the Bank of Japan’s director must have received blizzards of very sharp telephone calls from around Earth on Monday.

“Don’t you dare do that again!”

We hazard Mr. Ring is correct.

Thus Japan pays a steep, steep price for decades and decades of currency debasement, interest rate manipulation and kicking cans down roadways.

Yesterday’s difficult choice becomes today’s more difficult choice becomes tomorrow’s impossible choice.

Japan is in an impossible fix today because it refused to confront yesterday’s difficult choice.

Only by happy accident — boasting the world’s premier reserve currency — has the United States avoided an identical fix.

Yet as the world attempts to wriggle itself out of the dollar, that happy accident may switch to an unhappy accident in the years ahead.

On some semi-distant tomorrow… the United States may well and truly turn Japanese…

The post The High Cost of Cheap Money appeared first on Daily Reckoning.

This story originally appeared in the Daily Reckoning . The Daily Reckoning, offers a uniquely refreshing, perspective on the global economy, investing, gold, stocks and today’s markets. Its been called “the most entertaining read of the day.


Source: https://dailyreckoning.com/the-high-cost-of-cheap-money/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Lion’s Mane Mushroom Nootropic

Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.


 


Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.


Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.


Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.


Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.


Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.